* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
CSWYF's PEG Ratio is ranked better than 90.8% of 348
companies
in the Drug Manufacturers industry
Industry Median: 1.72
vs CSWYF: 0.42
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
China Shineway Pharmaceutical Group (OTCPK:CSWYF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
China Shineway Pharmaceutical Group PEG Ratio Related Terms
China Shineway Pharmaceutical Group PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group PEG Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's PEG Ratio distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
China Shineway Pharmaceutical Group (CSWYF) has a PEG Ratio of 0.43 as of Jun. 24, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 33% below median its historical median of 0.64. Over the past decade, China Shineway Pharmaceutical Group's PEG Ratio has ranged from 0.42 to 22.05. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #32 out of 348 companies in the Drug Manufacturers industry, placing it in the top 9.2%.
Is China Shineway Pharmaceutical Group's PEG Ratio too high?
China Shineway Pharmaceutical Group's current PEG Ratio of 0.43 is 33% below median its 10-year median of 0.64. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 22.05. The Drug Manufacturers industry median PEG Ratio is 1.72. China Shineway Pharmaceutical Group's value of 0.43 is 75% below this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #32 out of 348 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's PEG Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #32 out of 348 companies for PEG Ratio. This places China Shineway Pharmaceutical Group in the top 9% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.72. China Shineway Pharmaceutical Group's value of 0.43 is 75% below this benchmark. Historically, China Shineway Pharmaceutical Group's own PEG Ratio has ranged from 0.42 to 22.05 over the past decade. While the company's 10-year median is 0.64 vs. the industry median of 1.72, China Shineway Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.72, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current PEG Ratio of 0.43 is 75% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current PEG Ratio is 0.43, which is 33% below median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYF) has a current PEG Ratio of 0.43. The stock's GF Value™ is $0.88, compared to a current price of $1.00 — trading 14.1% above its estimated fair value. The current PEG Ratio is 0.43, which is 33% below median its 10-year median of 0.64 and 75% below the Drug Manufacturers industry median of 1.72. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYF), the current PEG Ratio is 0.43 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $1.00 is trading 14.1% above its estimated GF Value™ of $0.88.
Key valuation signals for CSWYF:
PEG Ratio: 0.43 (33% below median its 10-year median of 0.64)
GF Value™: $0.88 vs. price of $1.00 (14.1% above fair value)
Industry Position: 75% below the Drug Manufacturers median (#32 of 348)
No single metric tells the full story. See the CSWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score
Get the complete analysis for CSWYF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYF has been successfully added to your 
